Stille AB Total Liabilities
Stille AB total liabilities. Based on the latest financial reports, Stille AB (STIL) has total liabilities worth Skr362.30 Million SEK (≈ $38.99 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Stille AB liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Stille AB (2008–2024)
Total liabilities of Stille AB from 2008 to 2024. This chart illustrates how Stille AB's total liabilities have evolved over time, based on quarterly financial data. Explore Stille AB strategic investment ratio to see how much of total assets are deployed in long-term investments.
Stille AB Competitors by Total Liabilities
The table below lists competitors of Stille AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Provident Bancorp Inc
NASDAQ:PVBC
|
USA | $1.25 Billion |
|
Icelandair Group hf
IC:ICEAIR
|
Iceland | Ikr1.77 Billion |
|
Invercap
SN:INVERCAP
|
Chile | CL$3.34 Billion |
|
Hiron-Trade Investments & Industrial Buildings Ltd
TA:HRON
|
Israel | ILA349.64 Million |
|
ICBC Turkey Bank AS
IS:ICBCT
|
Turkey | TL93.98 Billion |
|
Standard Biotools Inc
NASDAQ:LAB
|
USA | $87.25 Million |
|
Zhangjiagang Haiguo New Energy Equipment Manufacturing Co. Ltd.
SHE:301063
|
China | CN¥1.09 Billion |
|
Anhui Hyea Aromas Co Ltd
SHE:300886
|
China | CN¥130.08 Million |
Liability Composition Analysis (2008–2024)
This chart breaks down Stille AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Stille AB.
Liquidity & Leverage Metrics
Stille AB Total Liabilities Ratios Explained
Stille AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Stille AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Stille AB (2008–2024)
The table below shows the annual total liabilities of Stille AB from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Skr301.70 Million ≈ $32.47 Million |
+74.76% |
| 2023-12-31 | Skr172.64 Million ≈ $18.58 Million |
+13.03% |
| 2022-12-31 | Skr152.74 Million ≈ $16.44 Million |
-4.99% |
| 2021-12-31 | Skr160.75 Million ≈ $17.30 Million |
+198.50% |
| 2020-12-31 | Skr53.85 Million ≈ $5.80 Million |
-9.39% |
| 2019-12-31 | Skr59.43 Million ≈ $6.40 Million |
+103.51% |
| 2018-12-31 | Skr29.20 Million ≈ $3.14 Million |
+38.17% |
| 2017-12-31 | Skr21.14 Million ≈ $2.27 Million |
+16.80% |
| 2016-12-31 | Skr18.10 Million ≈ $1.95 Million |
-11.82% |
| 2015-12-31 | Skr20.52 Million ≈ $2.21 Million |
+19.03% |
| 2014-12-31 | Skr17.24 Million ≈ $1.86 Million |
-17.85% |
| 2013-12-31 | Skr20.99 Million ≈ $2.26 Million |
-27.70% |
| 2012-12-31 | Skr29.03 Million ≈ $3.12 Million |
+18.18% |
| 2011-12-31 | Skr24.56 Million ≈ $2.64 Million |
+50.80% |
| 2010-12-31 | Skr16.29 Million ≈ $1.75 Million |
-31.05% |
| 2009-12-31 | Skr23.62 Million ≈ $2.54 Million |
-6.24% |
| 2008-12-31 | Skr25.20 Million ≈ $2.71 Million |
-- |
About Stille AB
Stille AB develops, manufactures, and distributes medtech products in Sweden and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascu… Read more